No Data
No Data
Twist Bioscience Is Maintained at Overweight by Barclays
Express News | Twist Bioscience : Barclays Raises Target Price to $60 From $45
Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $60
Barclays analyst Luke Sergott maintains $Twist Bioscience(TWST.US)$ with a buy rating, and adjusts the target price from $45 to $60.According to TipRanks data, the analyst has a success rate of 40.5%
Here's Why We're Not At All Concerned With Twist Bioscience's (NASDAQ:TWST) Cash Burn Situation
Twist Bioscience Is Maintained at Buy by TD Cowen
TD Cowen Maintains Buy on Twist Bioscience, Raises Price Target to $65